Acquired L1196M ALK mutation in anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma during alectinib administration
- Resource Type
- article
- Source
- eJHaem, Vol 4, Iss 1, Pp 305-308 (2023)
- Subject
alectinib resistance ALK‐positive anaplastic large cell lymphoma gatekeeper mutation L1196M ALK mutation leukemic presentation Diseases of the blood and blood-forming organs RC633-647.5 - Language
- English
- ISSN
- 2688-6146